WHO ICTRP trial
The effect of bupivacaine liposomes for thoracic paravertebral nerve block on…
ChiCTR2400087650 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400087650 |
|---|---|
| Public title | The effect of bupivacaine liposomes for thoracic paravertebral nerve block on postoperative analgesia after thoracoscopy |
| Scientific title | The effect of bupivacaine liposomes for thoracic paravertebral nerve block on postoperative analgesia after thoracoscopy |
| Primary sponsor | The Second Affiliated Hospital of Air Force Military Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Chronic postoperative pain |
| Interventions | Bupivacaine liposome group:20 mL 266 mg bupivacaine liposomes+10 mL 0.9% physiological saline;Bupivacaine group:0.5% bupivacaine hydrochloride 30 mL |
| Registration date | Jul 31, 2024 |
| Target size | Bupivacaine liposome group:73;Bupivacaine group:73 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: